TP53 Alterations in Myelodysplastic Neoplasms and Acute Myeloid Leukemia

Explore an invited speaker presentation focusing on TP53 alterations in myelodysplastic neoplasms and acute myeloid leukemia. Gain insights from Joseph Khoury's talk at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting, introduced by Panieh Terraf. Delve into the latest research and clinical implications of TP53 mutations in these hematological malignancies. Learn about the Cancer Genomics Consortium's mission to promote best practices in clinical cancer genomics and their goal of ensuring accurate genomic diagnoses for all cancer patients. Discover how this knowledge contributes to tailoring appropriate therapies for patients with myelodysplastic neoplasms and acute myeloid leukemia.